Abstract The Global Initiative for Chronic Obstructive Lung Disease (GOLD)
recommendations for the initial bronchodilator to use in newly diagnosed chronic obstructive …

Background Long-acting β 2-agonists (LABAs) and long-acting muscarinic antagonists
(LAMAs) are recommended as initial maintenance treatments for COPD, with their …

Clinical guidelines recommend long-acting bronchodilators as first maintenance therapy for
chronic obstructive pulmonary disease (COPD), with inhaled corticosteroids (ICS) reserved …

Introduction There is limited real-world evidence regarding clinical practice for chronic
obstructive pulmonary disease (COPD) in Singapore. We compared baseline clinical …

Background: Most patients with moderate and severe chronic obstructive pulmonary disease
(COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however …

Introduction Inhaled corticosteroids (ICS) are often prescribed inappropriately alongside
long-acting bronchodilators for chronic obstructive pulmonary disease (COPD). We aimed to …

Objective To compare the safety and effectiveness of long-acting β-antagonists (LABA), long-
acting antimuscarinic agents (LAMA) and inhaled corticosteroids (ICS) for managing chronic …

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity
and mortality globally. In the major revision of the Global Initiative for Chronic Obstructive …

Purpose Inappropriate use of an inhaled corticosteroid (ICS) for COPD has clinical and
economic disadvantages. This retrospective analysis of The UK Health Improvement …

This retrospective cohort study aimed to assess treatment patterns over 24 months amongst
patients with chronic obstructive pulmonary disease (COPD), initiating a new COPD …